Christopher Weber
About Christopher Weber
Christopher Weber is a Senior Scientist with extensive experience in high-throughput screening for drug development and a strong background in gene regulation and transcription factors. He has contributed to advancements in oncology research and has held various research positions at notable institutions, including ORIC Pharmaceuticals and Stanford University.
Work at ORIC Pharmaceuticals
Christopher Weber currently serves as a Senior Scientist at ORIC Pharmaceuticals Inc. in South San Francisco, California. He has held this position since 2022. Prior to this role, he worked as a Scientist at the same company from 2020 to 2022. His work primarily involves high-throughput screening (HTS) for drug development, contributing to the company's research initiatives in oncology.
Education and Expertise
Christopher Weber earned his Doctor of Philosophy (Ph.D.) in Molecular and Cellular Biology from the University of Washington, where he studied from 2008 to 2014. He also holds a Bachelor of Science (B.Sc.) in Biology from New Mexico State University, completed from 2001 to 2005. His academic background supports his specialization in gene regulation, transcription factors, and small molecule drug discovery.
Background in Research
Christopher Weber has a diverse research background, having worked at several prestigious institutions. He was a Postdoctoral Research Fellow at Stanford University from 2014 to 2020. He also completed his Ph.D. studies at Fred Hutchinson Cancer Research Center from 2008 to 2014. Earlier in his career, he served as an Undergraduate Research Associate at New Mexico State University from 2004 to 2006 and as a Staff Research Associate at the University of California, San Francisco from 2006 to 2008.
Specialization in Drug Discovery
Christopher Weber specializes in gene regulation and transcription factors, which are critical for target discovery and validation in drug development. He has a strong background in small molecule drug discovery, focusing on lead discovery and optimization. His extensive expertise in chromatin and epigenetics has contributed to advancements in oncology research.